Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT03444168 · ClinicalTrials.gov registry record

Central Nervous System Amplification in Lumbar Failed Back Surgery Syndrome

A clinical trial of Chronic Pain, sponsored by University of Kansas Medical Center.

Completed
Registry status
158
Enrollment target
1
Study location

NCT03444168: Completed study of Chronic Pain, sponsored by University of Kansas Medical Center.

NCT03444168 is a study of Chronic Pain that has completed, run by University of Kansas Medical Center. The registered enrollment target is 158 participants, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (80% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT03444168, a study of Chronic Pain, has completed, sponsored by University of Kansas Medical Center.

COMPLETED
Registry status
158 participants
Enrollment target
1
Study location

Study Summary

The purpose of this study is to learn whether or not certain risk factors and patient characteristics are linked with and possibly can predict the development of chronic pain after lumbar spine surgery.

Primary Outcome

Measured by the Brief Pain Inventory (BPI). The BPI scores are a numerical rating scale and range from 0 to 10. A score of 0 is equal to no pain and a score of 10 is equal to pain as bad as you can imagine.

Conditions Studied

Study Locations (1)

Kansas

  • University of Kansas Medical Center - Kansas City

Trial Details

FieldValue
Enrollment Target 158 participants
Start Date 2018-06-29
Est. Completion 2023-04-20
University of Kansas Medical Center

408 total trials

What the finished NCT03444168 record still lists

NCT03444168 is an observational study that tracks outcomes without assigning an intervention. The registered 158 participants enrollment target is mid-sized for trials with a published cap, below the 772-participant average among 301 other Chronic Pain trials with a reported enrollment target (80% lower).

The record links to 1 condition, with Chronic Pain appearing as the primary indexed condition, and to 0 interventions.

NCT03444168 reports a single indexed study location in Kansas.

Frequently Asked Questions

What is clinical trial NCT03444168 about?

NCT03444168 is a clinical study titled "Central Nervous System Amplification in Lumbar Failed Back Surgery Syndrome". The purpose of this study is to learn whether or not certain risk factors and patient characteristics are linked with and possibly can predict the development of chronic pain after lumbar spine surgery.

What is the current status of trial NCT03444168?

This trial is currently completed. The enrollment target is 158 participants. The study started on 2018-06-29. Estimated completion is 2023-04-20.

What conditions does trial NCT03444168 study?

This clinical trial studies the following conditions: Chronic Pain.

Who is sponsoring clinical trial NCT03444168?

This trial is sponsored by University of Kansas Medical Center, which has 408 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT03444168 being conducted?

This trial has 1 study location across Kansas. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Chronic Pain

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT03444168's enrollment target sits among peer trials

158 101st of 301 higher than 201 of 301 other Chronic Pain trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Chronic Pain trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04486833 · 158 participants · Phase 1

    Quaratusugene Ozeplasmid (Reqorsa) and Osimertinib in Patients With Advanced Lung Cancer Who Progressed on Osimertinib

  • NCT04697966 · 158 participants · NA

    Mechanisms and Predictors of Change in App-Based Mindfulness Training for Adolescents

  • NCT04969835 · 158 participants · Phase 1

    A Study Evaluating the Safety, Pharmacokinetics and Early Efficacy of AVA6000 in Solid Tumours

  • NCT05230732 · 158 participants · NA

    Neuromodulation of Inflammation and Endothelial Function

Similar registry start date

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

  • NCT07125183 · started 2026-12 · Phase 2

    Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma

  • NCT07292298 · started 2026-11 · Phase 2

    Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates

  • NCT04263285 · started 2026-10 · NA

    Treatment of Depression Post-SCI

Source: ClinicalTrials.gov NCT03444168, the US trial registry maintained by the National Library of Medicine. NCT03444168 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.